Using The Lung
To Heal Itself

Novel peptide therapeutics
for chronic lung diseases

Eldec has discovered naturally-occurring peptides in the lung which inhibit inflammation, tissue remodeling and fibrosis. These peptides are further optimized to increase potency and make them better drug candidates.

Learn More About Our Platform

Eldec’s lead ELD607 is a first-in-class modulator of Orai1, a key gatekeeper for inflammation and tissue remodeling. In multiple animal models of chronic lung disease, ELD607 has shown an unprecedented reversal of existing lung damage.

Learn More About Our Programs

Eldec’s founders are pioneers in the lung biology of Orai1 and identifying inhibitors of Orai1 that are naturally present in the lung.

At Eldec, we are not afraid to take on diseases where other potential therapies have been largely ineffective. We are relentless in our goal to advance new therapies for the benefit of patients who need them most.